Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow
19 mai 2022 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Obtains ISO 13485 Certification
18 mai 2022 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today that it has obtained ISO 13485:2016 certification...
Kane Biotech Announces Extension of Private Placement Offering
29 avr. 2022 16h05 HE
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Nuvoda Announces an Exclusive Partnership With ACWA Services Limited as Agent of Its Cutting-Edge Patented MOB™ Process Technology in the UK and Ireland
16 févr. 2022 08h45 HE
|
Nuvoda
RALEIGH, N.C., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Nuvoda, a research and technology firm to solve the world's water reuse issues, today announced ACWA Services Limited, a North Yorkshire UK...
Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Against Gram-Positive Bacteria
10 janv. 2022 06h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against...
Headworks International Announces Strategic Partnership in Ireland With Glan Agua
26 oct. 2021 03h00 HE
|
Headworks International Inc.
HOUSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Headworks International Inc. and Glan Agua Ltd. announced today that the companies have entered into a strategic channel partnership which will aim at...
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
19 août 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations
29 juil. 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant from the European Patent Office for patents covering its best-in-class...
Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units
21 juil. 2021 16h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 21, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has cancelled 8,470,555 stock options of...
Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amended and Restated Stock Option Plan
09 juin 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announced that, at the annual and special meeting of...